A comparative clinical evaluation of chitraka haritaki avaleha and bharangyadi avaleha in the management of tamaka shwasa(bronchial asthama) - TSCHABA

Director IPGT RA GAU JAMNAGAR0 sites30 target enrollmentTBD

Overview

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

4 years ago

Study Type

Interventional

Sponsor

Director IPGT RA GAU JAMNAGAR

•Patients of 2\-10 years of age of either sex.
•Diagnosed cases of Tamaka Shwasa with atleast 2 episodes of asthma symptoms during the previous year.
•Patients on other drug therapy will be included only after completion of wash out period of 3 weeks.

•Children of age below 2 years and above 10 years.
•Evidence of active Concomitants Pulmonary Disease other than asthma.
•Evidence of requirement of intubations for asthma, or had been hospitalized for asthma within one month before.Had Unresolved Sinus Disease or an unresolved upper or lower respiratory tract infection within 2 weeks.
•Patients on active Corticosteroid Therapy Or More Than 4 short courses of oral corticosteroids within the year preceding the screening visit,or any oral corticosteroids in the preceding 4 weeks.Use of Astemizole,Nedocromil, Cromolyn,long acting beta agonists,Ketotifen,or Theophylline within 2 weeks before.
•Concomitant severe de\-compensated systemic disease(cardiovascular,renal,hepatic,endocrine,hematological,neurological,immunological)